PHYTOPHARMACOLOGICAL COMPOSITION OF THE HYDROALCOHOLIC EXTRACT OF THE ROOT OF SECHIUM EDULE WITH HEPATOPROTECTIVE EFFECT

The present invention relates to the oral administration of Rse-HA prevented steatosis (fatty liver), hepatomegaly, hypertriglyceridemia, increased adipose tissue, hepatocellular necrosis, inflammation, and liver fibrosis, characteristics of Non-Alcoholic Steatohepatitis, induced by the chronic appl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JIMÉNEZ FERRER Jesús Enrique, ALVARADO OJEDA Zimri Aziel, COSTET MEJÍA Alejandro, ARELLIN ROSAS Gerardo, HERNÁNDEZ GARCÍA Brenda, FRAGOSO GONZÁLEZ Gladis Del Carmen, ROSAS SALGADO Gabriela, CASTRO MARTÍNEZ Gabriela, ZAMILPA ÁLVAREZ Alejandro, TREJO MORENO Celeste
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the oral administration of Rse-HA prevented steatosis (fatty liver), hepatomegaly, hypertriglyceridemia, increased adipose tissue, hepatocellular necrosis, inflammation, and liver fibrosis, characteristics of Non-Alcoholic Steatohepatitis, induced by the chronic application of Angiotensin II in the mouse. La administración oral del Rse-HA evitó la esteatosis (hígado graso), hepatomegalia, hipertrigliceridemia, el aumento del tejido adiposo, la necrosis hepatocelular, la inflamación y la fibrosis hepática, características de la Esteatohepatitis No Alcohólica, inducida por la aplicación crónica de Angiotensina II en ratón.